News
StockStory.org on MSN13h
1 Healthcare Stock on Our Buy List and 2 to Brush OffPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...
Second, we built a culture that values impact over broad activity. As AI increasingly handles routine tasks that once ...
AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...
Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...
The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...
GREmLN leverages a graph-based architecture to represent gene-gene interactions to predict cell behavior for therapeutic ...
The awards will be handed out at a gala event scheduled for October 9 at New York City’s Cipriani Wall Street.
Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...
A new report by the United Nations has four crucial recommendations on global governance of AGI. We must save ourselves from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results